Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1.
Wattenberg MM, Coho H, Herrera VM, Graham K, Stone ML, Xue Y, Chang RB, Cassella C, Liu M, Choi-Bose S, Thomas SK, Choi H, Li Y, Markowitz K, Melendez L, Gianonne M, Bose N, Beatty GL.
Wattenberg MM, et al. Among authors: cassella c.
Sci Immunol. 2023 Nov 17;8(89):eadj5097. doi: 10.1126/sciimmunol.adj5097. Epub 2023 Nov 17.
Sci Immunol. 2023.
PMID: 37976347
Free PMC article.